Compare ERNA & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERNA | CXAI |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 8.9M |
| IPO Year | 2021 | N/A |
| Metric | ERNA | CXAI |
|---|---|---|
| Price | $0.29 | $0.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 2.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.10 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $582,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 755.88 | N/A |
| 52 Week Low | $0.15 | $0.17 |
| 52 Week High | $3.00 | $1.49 |
| Indicator | ERNA | CXAI |
|---|---|---|
| Relative Strength Index (RSI) | 25.32 | 31.57 |
| Support Level | $0.27 | N/A |
| Resistance Level | $0.40 | $0.38 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 18.62 | 16.90 |
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.